Search

A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.

… Friday, July 13, 2018 Summary It is hard to monitor whether treatment for a brain tumor is having an effect. A new diagnostic technique called hyperpolarized MRI provides a clear image of the brain’s metabolic activity. This can give important clues about whether a treatment is working in a shorter time

Thousands of oncology experts from around the world will gather in Atlanta from March 29 – April 3 for the American Association for Cancer Research (AACR) Annual Meeting 2019. Memorial Sloan Kettering experts are involved in notable research presented at the meeting and are available to comment on topics including immunotherapy, precision medicine and targeted treatments, genomics, cancer interception and prevention, clinical trial design, cancer health disparities, and more. For more information and to set up interviews or access photos and video, contact [email protected] and [email protected].

… Thursday, March 28, 2019 Thousands of oncology experts from around the world will gather in Atlanta from March 29 – April 3 for the American Association for Cancer Research (AACR) Annual Meeting 2019. This year’s theme, “ Integrative   Cancer Science • Global Impact • Individualized Patient Care ,“ reinforces

A small interfering RNA implant targeting KRAS G12D/G12V mutations has shown a promising trend toward improved overall survival and objective response rate in patients with locally advanced pancreatic cancer with these mutations, according to results of a multisite, international phase 2 clinical trial led by Memorial Sloan Kettering Cancer Center.

… Thursday, January 29, 2026 A small interfering RNA (siRNA) implant targeting KRAS G12D/G12V mutations has shown a promising trend toward improved overall survival (OS) and objective response rate (ORR) in patients with locally advanced pancreatic cancer (LAPC) with these mutations, according to results

An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.

… Monday, April 8, 2024 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that  Jeffrey A. Drebin, MD, PhD , has been named President-Elect of the  American Surgical Association (ASA) for 2024. An internationally recognized surgeon-scientist and the Chair of MSK’s Department of Surgery,

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, including lung and endometrial cancers.

… Monday, October 28, 2024 Obesity or being overweight can  increase your risk of developing cancer . It can lead to chronic inflammation and hormonal changes, which can damage DNA and cause uncontrolled cell growth.  Now new research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may

In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.

… Friday, April 19, 2019 In a first-of-its-kind collaboration, Memorial Sloan Kettering has joined forces with the Chinese Thoracic Oncology Group (CTONG) — an alliance of more than 20 premier academic cancer centers in China — in an effort to establish a program of clinical trials that are open to patients

在史上首次该类型合作中，MSK 与中国胸部肿瘤研究协作组将携手共进，共同打造一个对来自美国和中国的患者都开放的临床试验项目。

… Friday, April 19, 2019 中国胸部肿瘤研究协作组 (CTONG) 是由 20 多个中国顶尖学术癌症中心组成的联盟。Memorial Sloan Kettering 首次与 CTONG 合作，努力促成一项对中美两国患者开放的临床试验项目。 该举措将重点关注 肺癌 精准治疗的临床试验。在中美两国，肺癌都是癌症致死的头号杀手。 此次合作于去年 12 月正式启动，旨在为中美两国的多中心 临床试验 奠定学术基础，最终目标是提高临床试验参与率，推动有效的新疗法尽快获批。 合作期间还实施了其他显著措施，包括远程医疗和教育举措，旨在改善两国患者的护理状况，并努力推动行业参与。 为获得该领域的指导

While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines.

… Thursday, April 23, 2020 While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines. Memorial Sloan Kettering Cancer Center (MSK) is encouraging our healthcare heroes to take a moment to recharge during this challenging time.

MSK molecular geneticist and data scientist Elli Papaemmanuil is leading an initiative to identify the genomic changes that drive pediatric tumors.

… Monday, September 30, 2019 Summary About half of pediatric tumors have a significant mutation that can be identified with standard clinical tests. MSK researchers are looking for a better way to detect mutations in the rest. MSK-IMPACT ™ detects changes in more than 400 cancer-associated genes. The test

New research from MSK investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies.

… Friday, May 24, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies. Anti-ceramide immunotherapy promising against